QC, C., H, X., M, G., X, G., HY, L., S, D., . . . XC, M. (2016). Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy. Dove Medical Press.
Chicago Style (17th ed.) CitationQC, Chu, et al. Liver-targeting Resibufogenin-loaded Poly(lactic-co-glycolic Acid)-D-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy. Dove Medical Press, 2016.
MLA (8th ed.) CitationQC, Chu, et al. Liver-targeting Resibufogenin-loaded Poly(lactic-co-glycolic Acid)-D-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy. Dove Medical Press, 2016.
Warning: These citations may not always be 100% accurate.